Drug
Inca036873
Inca036873: highest development phase Phase 1, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCA036873 NCT07195916 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Inca036873 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.